Metropolitan Life Insurance CO Agios Pharmaceuticals, Inc. Transaction History

Metropolitan Life Insurance CO

  • $281 Million
  • Q3 2024

Shares

53 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
SELL
$21.32 - $34.81 $8,890 - $14,515
-417 Reduced 12.36%
2,956 $86,000
Q3 2023

Nov 14, 2023
BUY
$24.36 - $28.18 $6,625 - $7,664
272 Added 8.77%
3,373 $83,000
Q1 2023

May 15, 2023
SELL
$21.74 - $30.93 $5,891 - $8,382
-271 Reduced 8.04%
3,101 $71,000
Q4 2022

Jun 14, 2023
BUY
$24.81 - $31.52 $6,723 - $8,541
271 Added 8.74%
3,372 $94.7 Million
Q3 2022

Jun 14, 2023
BUY
$19.51 - $34.14 $5,287 - $9,251
271 Added 8.74%
3,372 $95.4 Million
Q2 2022

Jun 20, 2023
BUY
$17.06 - $31.42 $4,623 - $8,514
271 Added 8.74%
3,372 $74,000
Q1 2022

Jun 20, 2023
BUY
$26.68 - $34.81 $7,230 - $9,433
271 Added 8.74%
3,372 $98,000
Q1 2022

Mar 30, 2023
SELL
$26.68 - $34.81 $325,309 - $424,438
-12,193 Reduced 78.34%
3,372 $98,000
Q1 2022

May 12, 2022
SELL
$26.68 - $34.81 $325,309 - $424,438
-12,193 Reduced 78.34%
3,372 $98,000
Q4 2021

Jun 21, 2023
BUY
$29.58 - $49.78 $368,685 - $620,457
12,464 Added 401.93%
15,565 $511,000
Q3 2021

Jun 21, 2023
BUY
$41.92 - $58.18 $522,490 - $725,155
12,464 Added 401.93%
15,565 $718,000
Q3 2021

Mar 30, 2023
SELL
$41.92 - $58.18 $57,262 - $79,473
-1,366 Reduced 8.07%
15,565 $718,000
Q3 2021

Nov 15, 2021
SELL
$41.92 - $58.18 $57,262 - $79,473
-1,366 Reduced 8.07%
15,565 $718,000
Q2 2021

Jun 21, 2023
BUY
$52.06 - $61.27 $719,989 - $847,364
13,830 Added 445.99%
16,931 $933,000
Q2 2021

Mar 30, 2023
BUY
$52.06 - $61.27 $859,146 - $1.01 Million
16,503 Added 3855.84%
16,931 $933,000
Q2 2021

Aug 16, 2021
BUY
$52.06 - $61.27 $881,427 - $1.04 Million
16,931 New
16,931 $933,000
Q1 2021

Jun 26, 2023
SELL
$44.23 - $57.5 $68,512 - $89,067
-1,549 Reduced 49.95%
1,552 $80.1 Million
Q1 2021

Mar 30, 2023
SELL
$44.23 - $57.5 $48,653 - $63,250
-1,100 Reduced 71.99%
428 $22,000
Q1 2021

May 14, 2021
SELL
$44.23 - $57.5 $67,583 - $87,860
-1,528 Closed
0 $22,000
Q4 2020

Jun 22, 2023
SELL
$33.21 - $46.54 $52,239 - $73,207
-1,573 Reduced 50.73%
1,528 $66,000
Q4 2020

Mar 30, 2023
SELL
$33.21 - $46.54 $1,394 - $1,954
-42 Reduced 2.68%
1,528 $66,000
Q4 2020

Feb 16, 2021
SELL
$33.21 - $46.54 $1,394 - $1,954
-42 Reduced 2.68%
1,528 $66,000
Q3 2020

Jun 26, 2023
SELL
$33.87 - $55.93 $51,854 - $85,628
-1,531 Reduced 49.37%
1,570 $54,000
Q3 2020

Mar 30, 2023
SELL
$33.87 - $55.93 $948 - $1,566
-28 Reduced 1.75%
1,570 $54,000
Q3 2020

Nov 13, 2020
SELL
$33.87 - $55.93 $948 - $1,566
-28 Reduced 1.75%
1,570 $55,000
Q2 2020

Jun 26, 2023
SELL
$34.45 - $53.48 $51,778 - $80,380
-1,503 Reduced 48.47%
1,598 $85,000
Q2 2020

Mar 30, 2023
SELL
$34.45 - $53.48 $5,236 - $8,128
-152 Reduced 8.69%
1,598 $85,000
Q2 2020

Aug 14, 2020
SELL
$34.45 - $53.48 $5,236 - $8,128
-152 Reduced 8.69%
1,598 $85,000
Q1 2020

Jul 12, 2023
SELL
$31.52 - $53.81 $42,583 - $72,697
-1,351 Reduced 43.57%
1,750 $62,000
Q1 2020

Mar 30, 2023
SELL
$31.52 - $53.81 $441 - $753
-14 Reduced 0.79%
1,750 $62,000
Q1 2020

May 15, 2020
SELL
$31.52 - $53.81 $441 - $753
-14 Reduced 0.79%
1,750 $62,000
Q4 2019

Jul 12, 2023
SELL
$30.08 - $50.59 $40,216 - $67,638
-1,337 Reduced 43.12%
1,764 $84,000
Q4 2019

Mar 30, 2023
BUY
$30.08 - $50.59 $7,369 - $12,394
245 Added 16.13%
1,764 $84,000
Q4 2019

Feb 14, 2020
BUY
$30.08 - $50.59 $7,369 - $12,394
245 Added 16.13%
1,764 $84,000
Q3 2019

Jul 12, 2023
SELL
$32.4 - $49.58 $51,256 - $78,435
-1,582 Reduced 51.02%
1,519 $49,000
Q3 2019

Mar 30, 2023
SELL
$32.4 - $49.58 $66,258 - $101,391
-2,045 Reduced 57.38%
1,519 $49,000
Q3 2019

Nov 14, 2019
SELL
$32.4 - $49.58 $66,258 - $101,391
-2,045 Reduced 57.38%
1,519 $49,000
Q2 2019

Jul 12, 2023
BUY
$46.17 - $68.1 $21,376 - $31,530
463 Added 14.93%
3,564 $177,000
Q2 2019

Mar 30, 2023
SELL
$46.17 - $68.1 $3,693 - $5,448
-80 Reduced 2.2%
3,564 $177,000
Q2 2019

Aug 14, 2019
SELL
$46.17 - $68.1 $3,693 - $5,448
-80 Reduced 2.2%
3,564 $178,000
Q1 2019

Jul 13, 2023
BUY
$45.92 - $67.67 $24,934 - $36,744
543 Added 17.51%
3,644 $245,000
Q1 2019

Mar 30, 2023
BUY
$45.92 - $67.67 $12,490 - $18,406
272 Added 8.07%
3,644 $245,000
Q1 2019

May 16, 2019
SELL
$45.92 - $67.67 $355,925 - $524,510
-7,751 Reduced 68.02%
3,644 $245,000
Q1 2019

May 15, 2019
BUY
$45.92 - $67.67 $352,436 - $519,367
7,675 Added 206.32%
11,395 $1.25 Million
Q4 2018

Jul 13, 2023
BUY
$42.73 - $76.53 $26,449 - $47,372
619 Added 19.96%
3,720 $171,000
Q4 2018

Feb 14, 2019
SELL
$42.73 - $76.53 $512 - $918
-12 Reduced 0.32%
3,720 $172,000
Q3 2018

Jul 13, 2023
BUY
$71.67 - $91.95 $45,223 - $58,020
631 Added 20.35%
3,732 $288 Million
Q3 2018

Nov 14, 2018
SELL
$71.67 - $91.95 $5,805 - $7,447
-81 Reduced 2.12%
3,732 $288,000
Q2 2018

Aug 15, 2018
BUY
$73.22 - $99.55 $21,526 - $29,267
294 Added 8.35%
3,813 $0
Q1 2018

May 15, 2018
BUY
$59.83 - $86.53 $33,624 - $48,629
562 Added 19.01%
3,519 $0
Q4 2017

Feb 15, 2018
SELL
$52.12 - $72.33 $1,667 - $2,314
-32 Reduced 1.07%
2,957 $169,000
Q3 2017

Nov 14, 2017
BUY
$54.89 - $67.12 $8,617 - $10,537
157 Added 5.54%
2,989 $200,000
Q2 2017

Aug 14, 2017
BUY
N/A
2,832
2,832 $146,000

Others Institutions Holding AGIO

# of Institutions
232
Shares Held
58.1M
Call Options Held
403K
Put Options Held
469K
View Full List

About AGIOS PHARMACEUTICALS, INC.

AGIO Quotes by TradingView
  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $3.26B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email